The US FDA has announced the launch of the Technology-Enabled Meaningful Patient Outcomes (TEMPO) for Digital Health Devices ...
Eli Lilly has appointed Carolyn Bertozzi to its Board of Directors as a returning member, after she served on Lilly’s board ...
Discover Jim Sage’s insights on leadership, industry challenges, and the transformative impact of data, technology, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback